Verona Pharma is developing novel treatments to enhance the lives of those affected by chronic lung conditions.
Science
Our first product is now approved by the US FDA and we continue to develop our pipeline of novel respiratory therapeutics.
COPD
Non-CF Bronchiectasis
Cystic Fibrosis
Asthma
Patients
Understanding the impact of chronic respiratory conditions on patients’ daily lives is vital to improving care.
Investors
Find out about our company’s performance, announcements and investor events.
Company
We’re a biopharmaceutical company focused on developing and commercializing innovative prescription medicines.
To learn more about Verona Pharma, please get in touch.